GlassScriptPhysician profile
Dina Winograd
NPI 1639598048
$4,451.15
in general payments reported to CMS, 2019-2025
35 companies · $740 in 2025
The $740 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $900 · 2021: $239 · 2022: $1,168 · 2023: $565 · 2024: $654 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,880 · Gift: $59.40 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,879.83 |
| Gift | $59.40 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $915.88 | 2020-2022 | |
| Novo Nordisk INC | $410.99 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Radius Health, INC. | $297.27 | 2021-2025 | Tymlos |
| Abbott Laboratories | $260.72 | 2022-2025 | Freestyle Libre |
| Amgen INC. | $254.13 | 2021-2025 | Evenity, Prolia, Tepezza |
| Dexcom, INC. | $231.27 | 2021-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $212.62 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Abbvie INC. | $197.42 | 2022-2025 | Synthroid |
| Insulet Corporation | $177.92 | 2022-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $154.35 | 2021-2025 | |
| Mannkind Corporation | $126.63 | 2021-2023 | Afrezza |
| Regeneron Healthcare Solutions, INC. | $122.07 | 2019 | |
| Xeris Pharmaceuticals, INC. | $107.40 | 2022-2025 | Gvoke Hypopen |
| Beta Bionics, INC. | $92.90 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ibsa Pharma INC. | $92.09 | 2022-2025 | Licart, Tirosint, Flector |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.07 | 2019-2022 | |
| Sequel Med Tech, LLC | $80.71 | 2025 | Twiist |
| Novartis Pharmaceuticals Corporation | $76.59 | 2022-2025 | |
| Horizon Therapeutics Plc | $64.64 | 2022-2023 | Tepezza |
| Amneal Pharmaceuticals LLC | $62.27 | 2021-2022 | |
| Antares Pharma, INC. | $57.55 | 2021-2022 | |
| Zealand Pharma US, INC. | $53.46 | 2021-2022 | |
| Cequr Corporation | $51.19 | 2022-2023 | Cequr Simplicity |
| Medtronic Minimed, INC. | $35.46 | 2019 | |
| Alexion Pharmaceuticals, INC. | $35.02 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $33.48 | 2022 | |
| Pfizer INC. | $26.66 | 2022 | |
| Astellas Pharma US INC | $23.50 | 2024 | Veozah |
| Amryt Pharma Holdings LTD | $18.81 | 2023 | Mycapssa |
| Corcept Therapeutics | $18.10 | 2022 | |
| Merck Sharp & Dohme LLC | $17.31 | 2023 | Steglatro |
| Shire North American Group INC | $16.78 | 2019 | |
| Currax Pharmaceuticals LLC | $16.76 | 2025 | Contrave |
| Esperion Therapeutics, INC. | $14.65 | 2024 | Nexletol |
| Medicure Pharma INC. | $13.48 | 2023 | Zypitamag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Winograd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.